TD Cowen raised the firm’s price target on Insulet (PODD) to $379 from $324 and keeps a Buy rating on the shares. The firm said its target increase is based on its stellar 1Q and the April appointment of Ashley McEvoy as CEO who they think will continue to press on the year-to-date drivers of T2 growth.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD: